The World Anti-Doping Agency (WADA) banned BPC-157 effective January 1, 2022, classifying it under the S0 (Unapproved Substances) category
You Could Develop a Tolerance Over time, youll build a tolerance to the med, so it becomes less effective
Additionally, there is mounting concern among doctors who view the non-traditional" (e.g., D2C companies, telehealth platforms) weight loss drug market as problematic, according to a December 2024 Sermo survey
The thigh has slightly slower absorption dynamics compared to the abdomen, which prevents a rapid initial spike of the medication in your bloodstream while delivering identical long-term weight loss results
Wegovy is administered as a once-weekly subcutaneous injection and works systemically by affecting appetite regulation centres in the brain